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The yolk sac is phylogenetically the oldest of the extraembryonic
membranes. The human embryo retains a yolk sac, which goes
through primary and secondary phases of development, but its
importance is controversial. Although known to synthesize pro-
teins, transport functions arewidely considered vestigial. Here, we
report RNA-Seq data for the human andmurine yolk sacs, and com-
pare with data for the chicken. We also relate the human RNASeq
data to proteomic data for the coelomic ﬂuid bathing the yolk sac.
Conservation of transcriptomes across the species indicates that
the human secondary yolk sac likely performs key functions early
in development, particularly uptake and processing of macro- and
micronutrients, many of which are found in coelomic ﬂuid. More
generally, our ﬁndings shed light on evolutionary mechanisms
that give rise to complex structures such as the placenta. We iden-
tify genetic modules that are conserved across mammals and birds,
suggesting these are part of the core amniote genetic repertoire
and are the building blocks for both oviparous and viviparous
reproductive modes. We propose that although a choriovitelline
placenta is never established physically in the human, the placental
villi, the exocoelomic cavity and the secondary yolk sac function
together as a physiological equivalent.
yolk sac j placenta j evolution
Introduction
The yolk sac is phylogenetically the oldest of the extraembryonic
membranes, evolving in anamniotes to absorb nutrients from
their lipid-rich megalecithal eggs (1). Although the ova of euthe-
rianmammals aremicrolecithal, the yolk sac has been recruited to
transport maternal nutrients during earliest stages of embryonic
development. In the majority of species, it makes contact with
the chorion to form a transient choriovitelline placenta. This
functions during the critical period of organogenesis, at the end
of which its functions are generally subsumed by the definitive
chorioallantoic placenta. There is, however, considerable species
variation, and themost elaborate development is found in rodents
and lagomorphs. In these, the yolk sac continues to transport
nutrients and immunoglobulins throughout gestation in parallel
with the chorioallantoic placenta. For this reason, most of the
experimental data on transport have been obtained in the mouse,
rat and guinea pig (2-6), and data on the human yolk sac are
limited.
The human yolk sac goes through two developmental phases:
a primary yolk sac which develops between embryonic days 7 and
9 and is replaced by a secondary yolk sac which is active until day
49 (7). The role of the primary yolk sac is unknown. The impor-
tance of the secondary yolk sac remains controversial. Although
it is known to synthesize proteins, such as alpha fetoprotein, its
transport functions are widely considered vestigial. Primarily, this
is because the secondary yolk sac never makes contact with the
chorion to form a choriovitelline placenta. Instead, it floats in
the exocoelomic cavity, connected to the embryo by the vitelline
duct. Although we, and others, have speculated that the yolk
sac plays a critical role during organogenesis (3-5, 8-10), there
are limited data to support this claim. Obtaining experimental
data for the human is impossible for ethical reasons, and thus we
adopted an alternative strategy. Here, we report RNA-Seq data
derived from human and murine yolk sacs, and compare them
with published data from the yolk sac of the chicken.We postulate
that conservation of transcripts across these species indicates
retention of key transport and synthetic functions. We support
this hypothesis by comparing the human yolk sac transcriptome
with the proteome of the coelomic fluid.
Results and Discussion
Wedetermined the transcript profile for the first trimester human
yolk sac by RNA-Seq with a median sequencing depth of 39
million mapped reads per sample (n=9, SI Appendix Table S1).
We identified 12469 transcripts with a mean RPKM (Read Per
Kilobase Per Million Mapped Reads) ≥1 (Dataset S1). Similarly,
we identified 11628 transcripts in first trimester human placen-
tal villous samples (n=11, median sequencing depth 30 million
mapped reads, Dataset S2) and 11272 transcripts in the mouse
yolk sac (n=8, median sequencing depth 28 million mapped
reads, Dataset S3).
In addition, we investigated the protein composition of the
coelomic fluid using GELC-MS/MS. We focused on the 165
proteins identified in any 4 of the 5 samples having excluded
immunoglobulins (Dataset S4). Proteins were mapped to unique
Signiﬁcance
The human yolk sac is often considered vestigial. Here, we
report RNA-Seq analysis of the human and murine yolk sacs,
and compare with that of the chicken. We relate the human
RNA-Seq data to coelomic ﬂuid proteomic data. Conservation
of transcripts across the species indicates the human secondary
yolk sac likely performs key functions early in development,
particularly uptake and processing of macro- and micronutri-
ents, many of which are found in coelomic ﬂuid. More gener-
ally, our ﬁndings shed light on evolutionary mechanisms giv-
ing rise to complex structures such as the placenta.We propose
that although a choriovitelline placenta is never established
physically in the human, the placental villi, exocoelomic cavity
and secondary yolk sac function together as a physiological
equivalent.
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Fig. 1. Chord plot illustrating the GO biological process terms that include
“cholesterol” and that are overrepresented in the 400 most abundant yolk
sac transcripts on the right, and the genes contributing to that enrichment
on the left arranged in order of their expression level.
Ensembl gene identifiers, which were used to identify over-
represented GO terms (Dataset S5).
Cholesterol
We selected the 400 most abundant human yolk sac tran-
scripts and identified enriched gene ontology (GO) terms using
Panther (complete reference database with Bonferroni correc-
tion, Dataset S6). Several terms associated with lipid transport
were enriched, for example “very-low-density lipoprotein particle”
(23 fold, P=4.5x10-7). Indeed, “cholesterol” featured in many of
the enriched “biological process” terms (Figure 1). Cholesterol
is required for development (3, 5) as it maintains integrity of
cell membranes (11), mediates metabolism through propaga-
tion of signaling pathways (12), and is the precursor for steroid
hormones. In addition, activity of sonic hedgehog (SHH) pro-
teins, which are responsible for the development of the central
nervous system (13-15) is determined by covalent modification
with cholesterol and other lipids (16). During organogenesis, the
embryo is reliant on maternal sources of cholesterol until its liver
is sufficiently mature for synthesis (4, 17). Our data show that
the human yolk sac contains abundantmRNAs encodingmultiple
apolipoproteins, the cholesterol efflux transporter ABCA1, as
well as lipoprotein receptors, including megalin, cubilin (18),
albeit at lower levels (Figure 1). Also present are transcripts en-
coding all classes ofABC transportors (A toG), which, in addition
to transporting cholesterol and lipids, facilitate excretion of toxins
and confer multidrug resistance (Table 1). The high abundance
(i.e. top 0.5%) of transcripts encoding apolipoproteins present in
lipoprotein particles and chylomicrons (ApoB, ApoA1, ApoA2
and ApoA4) is matched by the high levels of these proteins in the
Table 1. Categorisation of ABC transporters detected in human
yolk sac tissue
Family Transporters
detected in human
YS
Function
ABCA ABCA1*#, ABCA2,
ABCA3*#, ABCA5,
ABCA7*
Responsible for the
transportation of cholesterol and
lipids.
ABCB ABCB1*#,
ABCB10*#,
ABCB6*#,
ABCB7*#, ABCB8*#
Several of the B family members
are known to confer multidrug
resistance in cancer cells. Some
are located in the blood–brain
barrier, liver, mitochondria,
transports peptides and bile.
ABCC ABCC1*#,
ABCC10*#,
ABCC2*, ABCC3,
ABCC4*#,
ABCC5*#,
ABCC6*#,
ABCC6P1*,
ABCC6P2*
Ion-channel and toxin excretion
activity and reception on the cell
surface; toxin excretion (fungal
and bacterial toxins). Includes the
CFTR protein, mutations in which
cause cystic ﬁbrosis.
ABCD ABCD1*#,
ABCD3*#,
ABCD4*#
Are all used in peroxisomes.
ABCE/F ABCE1*#, ABCF1*#,
ABCF2*#, ABCF3*#
Not proper transporters; members
contain ATP-binding domains
without the transmembrane
domain. Involved in regulating
protein synthesis or expression.
ABCG ABCG1*, ABCG2*#,
ABCG5*#, ABCG8*
Transports lipids, diverse drug
substrates, bile, cholesterol, and
other steroids.
* also present in the mouse yolk sac; # also present in the chick yolk sac
coelomic fluid (Dataset S4). Indeed, most of the proteins found in
coelomic fluid are highly ranked in the RNA-Seq data (although
some were undetectable, i.e. below the RPKM ≥ 1 threshold).
Many of these proteins have functions associated with cholesterol
or lipid transport and metabolism (Figure 2).
The fluid of the exocoelom shares many proteins in common
with maternal plasma, supplemented by the addition of specific
decidual, trophoblastic and yolk sac proteins. Analogous to ma-
ternal serum proteins (20), coelomic fluid proteins can be broadly
categorized into common circulating proteins, coagulation and
complement factors, blood transport and binding proteins, pro-
tease inhibitors, proteases and other enzymes, cytokines and hor-
mones, channel and receptor-derived peptides andmiscellaneous
(SI Appendix Table S2) (21, 22).
Transport
The secondary yolk sac comprises an outer mesothelial ep-
ithelium and an inner endodermal layer, separated by dilated
capillaries and a small amount of mesoderm (23). Both the
mesothelial and endodermal epithelia display ultrastructural fea-
tures typical of an absorptive epithelium, including numerous
microvilli, coated pits and pinocytotic vesicles. The GO term
“transport” (GO:0006810) was overrepresented in the top 400
yolk sac transcripts (2.87 fold, p=7.16 x 10-47). Many such an-
notated transcripts were present in the most abundant 20% of
transcripts (87) (Dataset S5). Most of these transporter genes are
members of the solute carrier (SLC) family of transporters (for
example: SLC38A2 (amino acids), SLC4A1 (anions), SLC20A1
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Fig. 2. Chord plot illustrating proteins present in the coelomic ﬂuid
that relate to GO biological process terms involving “cholesterol” and “lipid
transport”. The presence of these proteins is consistent with the high level of
their transcripts in the human yolk sac illustrated in Figure 1.
(phosphate) and SLC25A37 (iron in the mitochondria)). Tran-
scripts encoding 259 SLC transporters were identified (mean
RPKM ranged from 134 to 1). We classified these transporters
into 11 main groups on the basis of substrate category (24),
i.e. amino acids, urea cycle, glucose, nucleoside sugars, metals,
vitamins, neurotransmitters, inorganic ions, thyroid, organic ions,
and miscellaneous, and matched them to their main substrates
that we and others (21, 22, 25-35) have identified in coelomic fluid
samples (Table 2). Zinc is the second most abundant trace ele-
ment, and is critical for embryonic development. It plays a role in
numerous biological processes, including cell division, growth and
differentiation and acts as a structural, catalytic and regulatory
component within transcription factors, enzymes, transporters
and receptors (36, 37). Absorbed zinc is mostly bound to albumin
and α2-macroglobulin, both of which are abundant in coelomic
fluid. In humans, zinc transport is mediated by 14 members of
the ZIP family (SLC39A) and 10 members of the ZnT family
(SLC30A). We detected mRNAs encoding 12 ZIP proteins and
8 ZnT proteins in the secondary yolk sac. Immunostaining for
the zinc transporter SLC39A7/ZIP7 was present in both the inner
endodermal and outer mesothelial epithelia, suggesting uptake
from the coelomic fluid and transport to the fetal circulation (Fig-
ure 3). The outer mesothelial layer also expresses α-tocopherol
transport protein to facilitate vitamin E transport (38). Thus,
our data suggest the human secondary yolk sac has a role in the
transport ofmultiple nutrients and vitamins, including iron (seven
iron-transporting SLC transcripts identified, Table 2) (39, 40),
vitamins A, B12, C, E, and folic acid (Table 2).
Total protein concentration is lower in coelomic fluid than
in maternal plasma. However, most amino acids are at higher
concentrations and must be derived from the villi and/or the
yolk sac. This suggests that the coelomic cavity is an important
route for metabolites required for embryonic development (25).
The secondary yolk sac floats within this nutrient-rich milieu.
It is therefore possible that uterine secretions supplemented by
maternal plasma from spiral arteries are taken up by the tro-
phoblast cells, passed via the villous stromal channels into the
exocoelomic cavity, from which they are taken up by the yolk sac
and transferred to the embryonic gut and the fetal circulation via
the vitelline duct (38). Thus, there appears to be free interchange
between these two compartments of the human gestational sac.
The passage across the trophoblast may require lysosomal
digestion ofmacromolecules, and indeed theGO term “lysosome”
(GO:0005764) is enriched 4-fold within the most abundant 400
villous transcripts (Bonferroni corrected P=7.99 x10-9). The ef-
flux amino acid transporters SLC43A2 and SLC7A8 are also
highly expressed (above the 95th and 83rd centiles, respectively).
In the rat it has been estimated that 95% of the amino acids
provided to the fetus in mid-gestation are obtained by lysosomal
digestion of endocytosedmaternal proteins (2). In themouse yolk
sac, transcripts encoding 5 lysosomal cathepsins (Ctsl, Ctsz, Ctsb,
Ctsd and Ctsh) are among the most abundant 400 transcripts,
the activity of which would allow for degradation and release
of free amino acids to the developing fetus. We have previously
shown that the mesothelial layer of the human yolk sac stains
for glycodelin, a product of the uterine glands and present in
high concentration in the coelomic fluid (41), indicating exposure
to intact maternal proteins and uptake (42). Glycodelin also
colocalizes with lysosomal Cathepsin D in human first trimester
villi (43). As in the mouse, several cathepsin transcripts (CTSB,
CTSZ, CTSL and CTSD) are extremely abundant in the human
secondary yolk sac. We found that the GO term “lysosome” is
enriched in the list of most abundant transcripts from yolk sacs
of human, mouse and chicken (2.79 fold P=1.35-3; 3.53 fold
P=9.72-5 and 3.6 fold P=2.13-3, respectively), indicating a similar
capacity for digestion of endocytosed macromolecules.
These findings indicate that the exocoelomic cavity is a phys-
iological liquid extension of the early placenta (44), and that the
yolk sac is an important route of access for high molecular weight
proteins to the embryonic circulation (45).
Hematopoiesis
In all vertebrates, primitive embryonic and definitive fe-
tal/adult blood cells form successively within the yolk sac, fetal
liver and bone marrow (46). The human secondary yolk sac is the
sole site of hematopoiesis for the first two weeks of pregnancy,
and the fetal liver commences blood cell production at week 6
of gestation (47, 48). The term “hemoglobin complex” was sig-
nificantly enriched among abundant yolk sac transcripts (33 fold,
P=2.95 x10-6). The yolk sac produces predominantly nucleated
erythrocytes, which synthesize embryonic hemoglobin (HBZ).
There is morphological evidence of the first blood islands in the
secondary yolk sac at about day 18 of gestation (49). Yolk sac-
derived primitive erythrocytes have been detected in the cardiac
cavity as early as the 3-somite stage (21 days), indicative of an
established functional network between the yolk sac and embryo
(50). The human yolk sac, like that of the mouse, also produces
macrophage and multipotential hematopoietic progenitors (48).
Transcription factors
Within the most abundant 400 transcripts in the human
yolk sac, 19 genes are annotated as "regulation of transcription,
DNA-templated" (GO:0006355), including several transcription
factors (ATF4, FOS, JUN, JUNB and JUND.) In the mouse
data set, 8 genes are similarly annotated (SI Appendix Table
S3). Candidate motifs recognized by these transcription factors
(where known) were identified in the 1kb and 5kb upstream
of the TSS of genes which were the highly correlated with the
transcription factor transcripts (Datasets S7-10). The FOS and
JUN families and AFT4 are closely related, functionally inter-
act, have multiple target genes and are widely expressed. There
273
274
275
276
277
278
279
280
281
282
283
284
285
286
287
288
289
290
291
292
293
294
295
296
297
298
299
300
301
302
303
304
305
306
307
308
309
310
311
312
313
314
315
316
317
318
319
320
321
322
323
324
325
326
327
328
329
330
331
332
333
334
335
336
337
338
339
340
Footline Author PNAS Issue Date Volume Issue Number 3
341
342
343
344
345
346
347
348
349
350
351
352
353
354
355
356
357
358
359
360
361
362
363
364
365
366
367
368
369
370
371
372
373
374
375
376
377
378
379
380
381
382
383
384
385
386
387
388
389
390
391
392
393
394
395
396
397
398
399
400
401
402
403
404
405
406
407
408
Submission PDF
Table 2. Categorization of SLC transporters detected in human yolk sac tissue
Substrate Category SLC transporters detected in human YS Known substrates Substrates detected in human
coelomic ﬂuid
Amino acids SLC38A2*#, SLC7A7*, SLC7A2, SLC1A5*, SLC38A3,
SLC3A2*, SLC3A1#, SLC25A38*, SLC38A4*, SLC38A10*,
SLC25A13*#, SLC7A8*, SLC7A6*#, SLC43A1*, SLC7A4,
SLC7A9*, SLC1A4*, SLC38A7*#, SLC7A1*, SLC15A4*#,
SLC38A5*, SLC7A6OS*#, SLC43A3*#, SLC38A9*#,
SLC43A2*#, SLC36A4*, SLC38A6*#, SLC38A11,
SLC6A17, SLC7A10
Ala, Asn, Cys, Gln, Gly, His,
Met, Pro, Ser, Glu, Trp, Asp
Thr, His, Arg, Val, Met, Ile, Leu, Phe,
Lys, Ser, Gln, Glu, Tau, Ala, Pro, Tyr,
Orn, Trp (21-22, 25-27)
Urea cycle SLC25A15*#, SLC2A9# Lys, Orn, Cit, Asp, Glu, uric
acid
Urea (28-29)
Glucose and sugars SLC2A1*#, SLC2A3*#, SLC2A4RG, SLC50A1*,
SLC2A2*#, SLC1A1#, SLC2A10#, SLC2A14, SLC5A9*,
SLC45A4*, SLC2A8*, SLC2A12, SLC2A6, SLC2A13#,
SLC37A1, SLC2A5#, SLC37A2#, SLC2A7*, SLC45A1,
SLC2A11, SLC2A1-AS1
glucose, galactose, fructose,
mannose, glucosamine
Glucose, galactose, fructose,
mannose, glucosamine,
galactosamine, erythritol, ribitol,
mannitol, inositol, glycerol, sorbitol
(22, 30)
Nucleoside sugars SLC35D2*, SLC17A9*, SLC35E2B#, SLC29A1*,
SLC35C2*#, SLC35A4*#, SLC35A2*, SLC35E1*#,
SLC25A36*#, SLC35D1*#, SLC35A5*#, SLC35F5*#,
SLC37A4*#, SLC35F6*, SLC35A3*#, SLC37A3*#,
SLC35B1*#, SLC35C1*, SLC52A2*, SLC29A2*,
SLC29A3*, SLC35B4*#, SLC35G1*, SLC35E3*#,
SLC29A4, SLC35F2*#, SLC35F3, SLC25A19*, SLC35G2*,
SLC28A1*
UDP-glucuronic acid,
UDP-galactose, UDP-N-
acetyl-galactosamine,
GDP-fructose
Metals SLC30A5*#, SLC30A9*#, SLC40A1*#, SLC39A7,
SLC39A14*#, SLC25A37*#, SLC39A6*, SLC39A5*,
SLC39A1*, SLC30A1*#, SLC31A1*#, SLC25A28*#,
SLC39A13*#, SLC39A9*#, SLC39A8*#, SLC11A2*#,
SLC30A6*#, SLC30A7*, SLC41A1*, SLC41A3*,
SLC39A11*#, SLC30A10*#, SLC31A2*, SLC39A10*,
SLC41A2#, SLC30A2*, SLC39A4*, SLC11A1, SLC39A3*,
SLC30A4*#
Zinc, iron, magnesium,
copper, cadmium, cobalt,
manganese, nickel, lead,
barium, strontium
Zinc, iron, cadmium, magnesium,
copper, manganese, lead, selenium
(28, 31, 32)
Vitamins SLC19A2*, SLC46A3*#, SLC25A32*#, SLC23A2*,
SLC5A6*, SLC46A1*#, SLC23A1*, SLC19A3*, SLC19A1*,
SLC23A3*
Thiamine (vitamin B1),
folate, ascorbic acid, biotin,
lipoate panthothenate,
thiamine
Vitamins A, E, B12, folate,
cobalamin, retinol binding protein
4, vitamin D binding protein (21,
27, 29, 33-35)
Neuro-transmitters SLC44A2*, SLC44A4*, SLC6A6*#, SLC44A1*#,
SLC36A1*#, SLC6A9*#, SLC1A3*, SLC6A13*, SLC44A3#,
SLC17A2, SLC25A22*#, SLC25A18, SLC25A12*#,
SLC17A4, SLC6A12
noradrenaline, serotonin,
dopamine, glutamate,
glycine, aspartate, choline
Glutamine, glutamic acid (21, 25)
Inorganic ions SLC25A3*#, SLC9A3R1*, SLC4A1*#, SLC20A1*,
SLC12A7*#, SLC4A2*#, SLC9A3R2*, SLC34A2*#,
SLC12A4*#, SLC26A6*, SLC9A1*, SLC20A2*, SLC9A6*#,
SLC4A1AP*, SLC9A9#, SLC26A11*#, SLC9B2, SLC26A2*,
SLC24A3, SLC9A8*, SLC12A8, SLC8B1*, SLC12A2*#,
SLC24A1, SLC4A7*, SLC12A6*, SLC4A3, SLC26A10,
SLC26A1*, SLC5A5, SLC9A7P1, SLC9A5*, SLC8A1,
SLC4A4*
Na+, K+, Cl-, HCO3-, Ca2+,
phosphate
Na+, K+, Cl-, HCO3-, Ca2+, phosphate
(28-29)
Thyroid SLC16A2#, SLC7A5*#, SLC16A10*# iodide, iodothyronines Tyrosine, thyroxine (26)
Organic ions SLCO2B1#, SLC22A7, SLC10A1, SLC10A3*, SLC22A23*#,
SLC51A*, SLC22A9, SLC22A17*, SLCO4C1*, SLCO2A1*,
SLC22A31, SLC22A18*#, SLC22A4*, SLC22A5*#,
SLC10A7*#, SLC51B, SLCO1B3, SLC22A15, SLC22A18AS,
SLCO1B1, SLCO3A1*#, SLC17A3, SLC22A3*
oestradiol, glucuronide,
bilirubin
bilirubin
Miscellaneous SLC25A5*, SLC5A12, SLC25A39*#, SLC25A1*#,
SLC16A3*, SLC35B2*, SLC25A20*, SLC17A5*#,
SLC16A1*#, SLC16A4#, SLC13A5, SLC35B3*, SLC6A8*,
SLC27A2*#, SLC25A24*#, SLC25A23*, SLC25A11*,
SLC25A44*, SLC25A25*, SLC45A3*, SLC15A1*,
SLC25A46*, SLC25A27, SLC25A42*, SLC27A3*,
SLC25A17*#, SLC25A43*#, SLC35A1*#, SLC12A9*#,
SLC16A5, SLC25A29#, SLC18B1*, SLC16A13*#,
SLC25A30*#, SLC27A4*#, SLC16A9*#, SLC48A1*#,
SLC33A1*#, SLC25A4*, SLC25A14*#, SLC25A33*,
SLC25A16*#, SLC25A40*, SLC25A34*, SLC27A1*#,
SLC25A26*, SLC47A1*#, SLC15A3, SLC16A12*#,
SLC25A45*, SLC5A11*, SLC25A51*, SLC13A3*#,
SLC16A14, SLC25A21-AS1, SLC16A7#, SLC16A6*,
SLC15A2, SLC27A5*, SLC17A1
ATP-ADP, carnitine,
creatinine, acetyl-CoA, sialic
acid, pyruvate, lactate,
ketone bodies, bile acids,
oxoglutarate, succinate,
citrate, ketoglutarate,
ornithine, acylcarnitine,
melanin, prostaglandin,
long-chain and very
long-chain fatty acids,
haem, ammonia, adenosine,
taurocholic acid
lactate, creatinine (29-30)
* also present in the mouse yolk sac; # also present in the chick yolk sac
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Fig. 3. Immunolocalization of ABCA1 and
SLC39A7/ZIP7 transporter proteins in the human yolk
sac at 11 weeks gestational age. Sections were im-
munostained with anti-ABCA1 or anti-ZIP7 antibod-
ies. In both cases, staining was present in the inner
endodermal and outer mesothelial layers, although it
was stronger in the former.
Fig. 4. Venn diagram comparing the most abundant 400 transcripts in the
human yolk sac, with ﬁrst trimester placental villi and adult liver, lung and
kidney. Transcripts shared by all ﬁve tissues (83) encoded principally house-
keeping proteins, whereas those shared uniquely with liver (35) encoded
proteins involved in cholesterol and lipid metabolism, suggesting the yolk
sac may perform these functions while the fetal liver develops. By contrast,
there are few transcripts shared uniquely with the kidney (5) suggesting the
yolk sac plays little role in excretion.
are numerous candidate binding sites in the highly expressed
human yolk sac genes (181 genes with sites for the FOS and
JUN families and ATF4, Datasets S7, 8) and 18 genes in the
mouse with candidate Atf4 binding sites (Datasets S9, 10). The
evidence used for the assignment of GO terms varies and for 2
genes (IGF2 andBHLHE40) depends on aNon-traceableAuthor
Statement (NAS, Dataset S3). Furthermore, binding motifs are
not available for all candidate factors even in the most recent
JASPAR database.
Yolk sac and villi compared to adult lung, liver and kidney
The inaccessibility of the human yolk sac severely constrains
any functional investigation of these candidate transcription bind-
ing sites. We therefore compared the human yolk sac transcript
profile with tissues where function has been better defined exper-
imentally. The placental villi serve similar functions to the adult
lung, liver and kidney, and we therefore compared the overlap
Fig. 5. Chord plot connecting GO Biological Process terms associated
with “lipid metabolism” and genes encoding transcripts that are shared by
the human yolk sac and adult liver. The overlap suggests the yolk sac may
perform hepatic functions while the fetal liver differentiates.
among the 400 most abundant transcripts from these tissues and
the yolk sac (Figure 4). The transcripts that are unique to each tis-
sue and those shared among these tissues are listed in the Dataset
S11. As expected, the transcripts shared by all 5 tissues encoded
abundant house-keeping proteins, such as ribosomal proteins
and those involved in mitochondrial energy generation with GO
terms such as “cytosolic small ribosome subunit”, “cytosolic large
ribosome subunit” and “mitochondrial respiratory chain” being
significantly overrepresented (P< 8.5x10-8 after Bonferroni cor-
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Fig. 6. Venn diagrams illustrating the overlap among
overrepresented GO terms associated with the 400
most abundant transcripts in each of the human,
mouse and chicken yolk sacs: A, “biological process”; B,
“cellular component” and C, “molecular function”. The
considerable overlap among the species in all three
categories suggests conservation of functions.
Fig. 7. Diagrammatic comparison of the nutrient pathway during early pregnancy in the mouse (A), and the speculated pathway in the human (B). In the
mouse, histotrophic secretions (green) released from the endometrial glands (EG) are phagocytosed (1) by the endodermal cells (E) of the visceral layer of
the inverted yolk sac (YS). Following fusion with lysosomes (2), digestion of maternal proteins leads to release of amino acids that are transported (3) to the
fetal circulation (FC). In the human, histotrophic secretions are released from the endometrial glands through the developing basal plate of the placenta into
the intervillous space (IVS), and are phagocytosed (1) by the syncytiotrophoblast (STB) (ref. 42). We speculate that following digestion by lysosomal enzymes
(2), free amino acids are transported (3) by efﬂux transporters to the coelomic ﬂuid (CF) where they accumulate. Nutrients in the CF may be taken up by the
mesothelial cells (M) of the yolk sac and transported (4) into the fetal circulation (FC). Alternatively, they may diffuse into the cavity of the yolk sac and be
taken up by the endodermal cells (5). Some intact maternal proteins may also be released into the CF by exocytosis of residual bodies (6), and be engulfed by
the mesothelial cells (7). CTB; cytotrophoblast cells.
rection, Dataset S12). The enriched GO terms associated with
the 35 transcripts shared only by the yolk sac and liver include
“high-density lipoprotein particle receptor binding”, “cholesterol
transporter activity”, “lipid transporter activity” (all greater than
28-fold enrichment and P< 2x10-4 after Bonferroni correction,
Dataset S13).
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Mouse Yolk Sac RNA-Seq data
On a comparative basis, the yolk sac provides an important
pathway for nutrient uptake in many species during early preg-
nancy (52, 53), and its role has been well documented in experi-
mental rodents, such as the rat and mouse (54). At the ultrastruc-
tural level, the endodermal layers of the human and rodent yolk
sacs display many similar morphological characteristic typical of
an absorptive epithelium (10, 55). However, their orientation is
different as the human yolk sac floats in the exocoelom with the
endodermal cell layer lining the interior of the sac, whilst the
rodent yolk is inverted with the endodermal layer facing outwards
following degeneration of the parietal layer (56, 57).
Cross-species comparison
To compare the most abundant transcripts in the human,
mouse and chicken yolk sac we identified the homologous genes
by mapping the human Ensembl gene identifiers to the corre-
sponding mouse and chicken Ensembl gene IDs using biomart
(release ENSEMBL Genes 85) Dataset S20. The raw and pro-
cessed chicken yolk sac data were obtained directly from the
authors (58). Gene ontology analysis was carried out as described
above, using the 400 most abundant chicken yolk sac transcripts
observed at E17 (Dataset S22). The intersection between the
over-represented GO terms in the human, mouse and chicken
yolk sacs was determined as described above (SI Appendix Table
S4). Venn diagrams showing the overlaps are shown in Figure
6. The P values for all the observed intersections are highly
significant (P< 1.70x10-22 and are summarized in Dataset S23).
The depth of the GO annotation varies between species and is
more limited in the chicken, which necessarily precludes detecting
a high degree of overlap with the human genes. Nonetheless,
shared biological process terms include “translation”, “ribosome
biogenesis”, “oxidation-reduction process” and “small molecule
metabolic process” reflecting cellular processes associated with
metabolically active tissue. Transcripts reflectingmore specialized
cellular function, such as lipid and cholesterol transport, which
are shared by the human yolk sac and liver (APOA1, APOA4,
APOB,RBP4, SEPP1, TTR) are also present among the 400most
abundant mouse and chicken yolk sac transcripts (P=2.3 x10-13).
Conclusion
Overall, our data show that the human secondary yolk sac
appears far from vestigial with little or no biological role, and that
it may perform many key functions in the early weeks of devel-
opment. In particular, it contains abundant transcripts encoding
an array of transporter proteins involved in the uptake of macro-
andmicronutrients. Our data showing the presence of transporter
proteins in both of the yolk sac epithelia, and their substrates in
coelomic fluid, support this concept and are consistent with the
morphological appearances of absorptive surfaces (23, 59, 60).
Our data also confirm significant synthetic activity, especially of
apolipoproteins, a function most likely performed in the endo-
dermal cells given their high content of endoplasmic reticulum
and Golgi cisternae (23, 59, 60). The handling of cholesterol,
which is essential for synthesis of cell and organelle membranes
as well as being a co-factor in signaling pathways involved in
axis determination and other fundamental developmental events,
appears of particular significance. Furthermore, the high level
of conservation of transcripts compared with the mouse and
the chicken, where the yolk sac is known to be essential for
development, suggests maintenance of function.
The secondary yolk sac is thus likely to be essential for the
survival of the embryo during the first weeks of development.
Morphological abnormalities of the secondary yolk sac have been
reported in 70% of first trimester human miscarriages (61), but
separating cause from effect is impossible.
More generally, our findings shed light on the evolutionary
mechanisms that give rise to complex structures such as the
placenta. The placenta has evolved repeatedly from an oviparous
background in mammals, reptiles and fish, sometimes over very
short timescales (62, 63). Development of a yolk sac for direct
maternal provisioning of the developing fetus is a common fea-
ture of such evolutionary transitions to the extent that the yolk sac
may be regarded as a "fundamental vertebrate fetal nutritional
system" (64). The yolk sacs studied in this paper constitute a
broad, albeit incomplete, sampling of the variation present in the
vertebrates. The inverted yolk sac placenta of the mouse is found
in several rodents and lagomorphs (1), but also in the distantly
related nine-banded armadillo (65). The "free floating" secondary
yolk sac of the human is found in the other haplorhine primates
(Macaca mulatta) (66) but also, surprisingly, in distantly related
Afrotherian species. The yolk sac floats freely in the exocoelom
in at least one tenrec species, the Nimba otter shrew (Microp-
otamogale lamottei) (67), in another Afrotherian insectivore, the
eastern rock elephant shrew (Elephantulus myurus) (68) and in
two species of bat (Myotis lucifugus (little brown bat) (69) and
Tadarida brasiliensis (70)). These observations suggest that both
mouse and human yolk sacs reflect convergent evolution toward
similar forms found elsewhere in the mammalian phylogenetic
tree. The yolk sac of the chicken, of course, is characteristic of
oviparous species: all birds and the majority of reptiles.
Under a classic Darwinian model of macroevolution, small
genetic mutations gradually occur and are accompanied by corre-
spondingly small phenotypic changes until, over time, a high de-
gree of morphological and functional diversification accumulates
between species that are distantly related. The results presented
here suggest, however, that the genetic systems underlying the
function of the yolk sac are robust. We identify a number of
genetic modules, including those involved in cholesterol process-
ing, lipid transport, redox processes and nutrient delivery which
were presumably reorganized and redeployed during evolution-
ary change while being internally conserved. These findings are
in line with an extended evolutionary-developmental model in
which it is the gene regulatory networks and underlying tran-
scriptional control elements which change (71). The repeated
convergent evolution of yolk sac placentas in all major groups of
vertebrates other than birds is characteristic of what has come
to be known as deep homology which describes the origin of
complex structures through modification and reorganization of
pre-existing genetic systems (72). Given that the modular con-
servation of systems active in the yolk sac is shown to extend
across mammals and birds, the common ancestor of which was a
reptile, it is possible that genetic modules of the yolk sac are part
of the core amniote genetic repertoire. That is, conserved genetic
systems of yolk sac function, for example cholesterol and lipid
metabolism, form part of the common heritage shared by all
mammals, reptiles and birds, and are the building blocks for both
oviparous and viviparous reproductive modes.
Our findings indicate that extensive high level morpholog-
ical diversification of the extraembryonic membranes masks a
surprising degree of functional conservation at the molecular
genetic level. Evolutionary conservation at the level of nucleotide
sequence, gene regulation and modularity of gene expression is
widely regarded as evidence of functional significance in both
healthy development and in disease (73-75). Therefore, we pro-
pose, that although a choriovitelline placenta is never established
physically in the human, the early placental villi, the exocoelomic
cavity and the secondary yolk sac combine to function as a physi-
ological equivalent (Figure 7).
Methods
Human tissue collection
Tissue and ﬂuid samples were collected with informed written patient
consent and approval of the Joint UCL/UCLH Committees on the Ethics of
817
818
819
820
821
822
823
824
825
826
827
828
829
830
831
832
833
834
835
836
837
838
839
840
841
842
843
844
845
846
847
848
849
850
851
852
853
854
855
856
857
858
859
860
861
862
863
864
865
866
867
868
869
870
871
872
873
874
875
876
877
878
879
880
881
882
883
884
Footline Author PNAS Issue Date Volume Issue Number 7
885
886
887
888
889
890
891
892
893
894
895
896
897
898
899
900
901
902
903
904
905
906
907
908
909
910
911
912
913
914
915
916
917
918
919
920
921
922
923
924
925
926
927
928
929
930
931
932
933
934
935
936
937
938
939
940
941
942
943
944
945
946
947
948
949
950
951
952
Submission PDF
Human Research (05/Q0505/82) from 7-12 weeks in uncomplicated preg-
nancies. Gestational age was conﬁrmed by ultrasound measurement of the
crown rump length of the embryo. All samples were collected from patients
undergoing surgical pregnancy termination under general anesthesia for
psycho-social reasons. Coelomic ﬂuid samples were obtained by transvaginal
puncture under sonographic guidance as previously described (27). Villous
samples were obtained under transabdominal ultrasound guidance from
the central region of the placenta using a chorionic villus sampling (CVS)
technique. Intact secondary yolk sacs were obtained by gentle aspiration
guided by ultrasound. All samples were snap frozen in liquid nitrogen and
stored at -80°C until analysis.
Mouse tissue collection
Yolk sacs were collected from time-mated virgin C57BL/6J mice. Exper-
iments were carried out in accordance with the United Kingdom Animals
Scientiﬁc Procedures Act 1986 which mandates ethical review. A single
randomly selected yolk sac was collected from each pregnant female at E9.5
(day of plug = E0.5). Tissuewas dissected free from decidua and amnion, snap
frozen and stored at -80°C until processing.
RNA extraction and RNA-Seq
RNA from human and mouse yolk sacs and human ﬁrst trimester
placental villi was extracted using RNeasy plus universal mini kit (Qiagen,
Cat No 73404). Libraries were made using the Illumina TruSeq Stranded
mRNA library kit according to the manufacturer’s instructions. Libraries were
quantiﬁed (kappa qPCR) and equimolar pools sequenced (single end 50 base
reads, SE50) in several lanes of the Illumina HiSeq2500. Additional details are
provided in the Supplemental Information.
Data availability
The data sets generated during the current study are available in the Eu-
ropean Nucleotide Archive (ENA http://www.ebi.ac.uk/ena) under the acces-
sion number PRJEB18767, http://www.ebi.ac.uk/ena/data/view/PRJEB18767.
Proteomic analysis of coelomic ﬂuid samples
Coelomic ﬂuid samples were run on 1D gels, enzymatically digested and
analyzed using LC-MS/MS (Dionex Ultimate 3000 RSLC nanoUPLC, Thermo
Fisher Scientiﬁc Inc, Waltham, MA, USA) system and a QExactive Orbitrap
mass spectrometer (Thermo Fisher Scientiﬁc Inc, Waltham, MA, USA). De-
tailed methods are described in the Supplemental ﬁle.
Immunohistochemistry
Immunohistochemistry was performed as previously described (76) using
the following primary antibodies: anti-SLC39A7 (ZIP7, Abcam, ab117560) and
anti-ABCA1 (Abcam, ab7360).
Supporting Information.
Additional methods and references (57, 77-87) are in the online supple-
mental methods.
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